Table 1.
TMIGD2 could offer as an independent factor to predict prognosis at median cutoff.
| Parameters | HR (95% CI) | p value |
|---|---|---|
| Gender | 0.900 (0.404-2.006) | 0.796 |
| Age | 1.813 (0.983-3.341) | 0.057 |
| Pathological grade | ||
| II vs. I | 20.260 (2.733-150.209) | 0.003∗ |
| III vs. I | 12.586 (1.599-99.072) | 0.016∗ |
| Tumor size | ||
| T2 vs. T1 | 1.097 (0.440-2.734) | 0.842 |
| T3 vs. T1 | 1.817 (0.672-4.909) | 0.239 |
| T4 vs. T1 | 2.164 (0.716-6.542) | 0.171 |
| Node stage | ||
| N1+N2 vs. N0 | 1.129 (0.628-2.029) | 0.685 |
| TMIGD2 | 1.924 (1.069-3.464) | 0.029∗ |
Cox proportional hazards regression model. HR: hazard ratio; 95% CI: 95% confidence interval. ∗ p < 0.05.